Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome

被引:10
|
作者
Khajuria, Bhavik [1 ]
Khajuria, Mansi [2 ]
Agrawal, Yashwant [3 ]
机构
[1] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA
关键词
posterior reversible encephalopathy syndrome; PRES; mycophenolate; mycophenolic acid;
D O I
10.1097/MJT.0000000000000270
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A 29-year-old woman presented with diffuse anasarca and shortness of breath. Workup revealed a creatinine of 3.3 and a glomerular filtration rate of 17. The patient was also found to be pancytopenic with evidence of hemolytic anemia. A renal biopsy showed evidence of stage IV lupus nephritis with rapidly progressive glomerulonephritis. Her lupus was further classified as ANA negative and anti-dsDNA positive. Mycophenolate and triweekly hemodialysis were started along with a steroid burst of methylprednisolone 1 g for 3 days followed by prednisone 60 mg daily. Four days after discharge, the patient represented with a witnessed 3-minute seizure involving bowel incontinence, altered mental status, and tongue biting. She was given 2 mg intravenous lorazepam and loaded with 1000 mg levetiracetam for seizure prophylaxis. Magnetic resonance imaging of the head revealed bilateral posterior hemispheric subcortical edema, and the diagnosis of posterior reversible encephalopathy syndrome was made. Mycophenolate was immediately discontinued and replaced with cyclophosphamide. Strict blood pressure control below 140/ 90 mm Hg was maintained initially with intravenous nicardipine drip and then transitioned to oral nifedipine, clonidine, losartan, and minoxidil. A repeat head magnetic resonance imaging 8 days later showed resolved subcortical edema consistent with the patient's improved mental status. No permanent neurologic sequelae were recorded as a result of this hospital episode.
引用
收藏
页码:E1072 / E1073
页数:2
相关论文
共 50 条
  • [41] Posterior reversible encephalopathy syndrome associated with nephrotic syndrome
    Zhang, Hong-Liang
    Yang, Yi
    Wu, Jiang
    NEUROENDOCRINOLOGY LETTERS, 2010, 31 (06) : 728 - 728
  • [42] Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma
    Asaithambi, G.
    Peters, B. R.
    Hurliman, E.
    Moran, B. P.
    Khan, A. S.
    Taylor, R. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 175 - 176
  • [43] Serotonin Syndrome Presenting as a Posterior Reversible Encephalopathy Syndrome
    Malik, Muhammad Taimur
    Majeed, Mohammad Faraz
    Zand, Ramin
    CASE REPORTS IN NEUROLOGY, 2020, 12 (01) : 63 - 68
  • [44] Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome
    Tenta, Masafumi
    Uchida, Haruhito Adam
    Nunoue, Tomokazu
    Umebayashi, Ryoko
    Okuyama, Yuka
    Kitagawa, Masashi
    Maeshima, Yohei
    Sugiyama, Hitoshi
    Wada, Jun
    CEN CASE REPORTS, 2015, 4 (02): : 190 - 195
  • [45] Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome
    Masafumi Tenta
    Haruhito Adam Uchida
    Tomokazu Nunoue
    Ryoko Umebayashi
    Yuka Okuyama
    Masashi Kitagawa
    Yohei Maeshima
    Hitoshi Sugiyama
    Jun Wada
    CEN Case Reports, 2015, 4 (2) : 190 - 195
  • [46] Asymmetric Posterior Reversible Encephalopathy Syndrome due to Hypertensive Encephalopathy
    Nishijima, Haruo
    Haga, Rie
    Suzuki, Chieko
    Tomiyama, Masahiko
    INTERNAL MEDICINE, 2015, 54 (08) : 993 - 994
  • [47] Posterior Reversible Encephalopathy Syndrome in Patients With Cancer
    Singer, Samuel
    Grommes, Christian
    Reiner, Anne S.
    Rosenblum, Marc K.
    Deangelis, Lisa M.
    ONCOLOGIST, 2015, 20 (07) : 806 - 811
  • [48] Recurrent posterior reversible encephalopathy syndrome (PRES)
    G Hagemann
    T Ugur
    O W Witte
    C Fitzek
    Journal of Human Hypertension, 2004, 18 : 287 - 289
  • [49] Recurrent posterior reversible encephalopathy syndrome (PRES)
    Hagemann, G
    Ugur, T
    Witte, OW
    Fitzek, C
    JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (04) : 287 - 289
  • [50] Posterior reversible encephalopathy syndrome and oral methotrexate
    Hart, Caroline
    Kinney, Michael O.
    McCarron, Mark O.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (06) : 725 - 727